RxSight annual capital expenditures (capex)
2020
2021
2022
2023
2024
2025
RxSight Capital Expenditures (CapEx) Growth & History (RXST)
RxSight's capital expenditures (capex) was $3.8M for fiscal 2025.
View full RxSight company overviewRxSight annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3.8M | −$1.6M | −29.60% |
| 2024 | 2024-12-31 | $5.4M | $626,000 | +13.00% |
| 2023 | 2023-12-31 | $4.8M | $2.4M | +101.17% |
| 2022 | 2022-12-31 | $2.4M | $453,000 | +23.35% |
| 2021 | 2021-12-31 | $1.9M | −$599,000 | −23.59% |
| 2020 | 2020-12-31 | $2.5M | — | — |
RxSight quarterly capital expenditures (capex)
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.0M | $419,000 | +27.26% |
| Q1 2026 | 2026-03-31 | $759,000 | $184,000 | +32.00% |
| Q4 2025 | 2025-12-31 | $1.1M | $290,000 | +34.24% |
| Q3 2025 | 2025-09-30 | $581,000 | −$522,000 | −47.33% |
| Q2 2025 | 2025-06-30 | $1.5M | $14,000 | +0.92% |
| Q1 2025 | 2025-03-31 | $575,000 | −$1.4M | −70.77% |
| Q4 2024 | 2024-12-31 | $847,000 | −$744,000 | −46.76% |
| Q3 2024 | 2024-09-30 | $1.1M | $450,000 | +68.91% |
| Q2 2024 | 2024-06-30 | $1.5M | −$300,000 | −16.46% |
| Q1 2024 | 2024-03-31 | $2.0M | $1.2M | +163.32% |
| Q4 2023 | 2023-12-31 | $1.6M | $1.2M | +339.50% |
| Q3 2023 | 2023-09-30 | $653,000 | $73,000 | +12.59% |
| Q2 2023 | 2023-06-30 | $1.8M | $742,000 | +68.64% |
| Q1 2023 | 2023-03-31 | $747,000 | $377,000 | +101.89% |
| Q4 2022 | 2022-12-31 | $362,000 | −$3,000 | −0.82% |
| Q3 2022 | 2022-09-30 | $580,000 | $326,000 | +128.35% |
| Q2 2022 | 2022-06-30 | $1.1M | $258,000 | +31.35% |
| Q1 2022 | 2022-03-31 | $370,000 | −$128,000 | −25.70% |
| Q4 2021 | 2021-12-31 | $365,000 | — | — |
| Q3 2021 | 2021-09-30 | $254,000 | −$349,000 | −57.88% |
| Q2 2021 | 2021-06-30 | $823,000 | — | — |
| Q1 2021 | 2021-03-31 | $498,000 | — | — |
| Q3 2020 | 2020-09-30 | $603,000 | — | — |
RxSight capital expenditures (capex) trends
Over the last five fiscal years, RxSight's capital expenditures (capex) increased from $2.5M to $3.8M, a change of $1.3M. The latest reported quarter, Q2 2026, shows $2.0M.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review RxSight source filings ↗